These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 26875892)

  • 1. Clinical significance of serum protease activated receptor1 levels in patients with lung cancer.
    Erturk K; Tastekin D; Bilgin E; Tas F; Disci R; Duranyildiz D
    Eur Rev Med Pharmacol Sci; 2016; 20(2):243-9. PubMed ID: 26875892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there any diagnostic value of serum protease-activated receptor-1 (PAR1) levels on determination of epithelial ovarian carcinoma?
    Karabulut S; Akşit E; Tas F; Ciftci R; Aydiner A; Yildiz I; Keskin S; Eralp Y; Yasasever CT; Vatansever S; Disci R; Saip P
    Tumour Biol; 2014 May; 35(5):4323-9. PubMed ID: 24390664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
    Fan J; Yu H; Lv Y; Yin L
    Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Cripto-1 is a novel biomarker for non-small cell lung cancer diagnosis and prognosis.
    Xu CH; Wang Y; Qian LH; Yu LK; Zhang XW; Wang QB
    Clin Respir J; 2017 Nov; 11(6):765-771. PubMed ID: 26605871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of serum Bcl-2 levels in advanced lung cancer patients.
    Tas F; Duranyildiz D; Oguz H; Camlica H; Oral EN; Yasasever V; Topuz E
    Med Oncol; 2005; 22(2):139-43. PubMed ID: 15965276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of serum sMICA levels in non-small cell lung cancer.
    Wang LP; Niu H; Xia YF; Han YL; Niu P; Wang HY; Zhou QL
    Eur Rev Med Pharmacol Sci; 2015 Jun; 19(12):2226-30. PubMed ID: 26166647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of leptin and proinflammatory cytokines in advanced-stage non-small cell lung cancer.
    Tas F; Duranyildiz D; Argon A; Oğuz H; Camlica H; Yasasever V; Topuz E
    Med Oncol; 2005; 22(4):353-8. PubMed ID: 16260852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic value of serum periostin in patients with non-small cell lung cancer.
    Xu CH; Wang W; Lin Y; Qian LH; Zhang XW; Wang QB; Yu LK
    Oncotarget; 2017 Mar; 8(12):18746-18753. PubMed ID: 27816968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between Glasgow Prognostic Score and serum tumor markers in patients with advanced non-small cell lung cancer.
    Jiang AG; Chen HL; Lu HY
    BMC Cancer; 2015 May; 15():386. PubMed ID: 25956656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Significance of HMGB-1 and TGF-β Level in Serum and BALF of Advanced Non-Small Cell Lung Cancer.
    Jakubowska K; Naumnik W; Niklińska W; Chyczewska E
    Adv Exp Med Biol; 2015; 852():49-58. PubMed ID: 25753556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the clinical significance of serum HE4 levels in lung cancer and pulmonary tuberculosis.
    Liu W; Yang J; Chi PD; Zheng X; Dai SQ; Chen H; Xu BL; Liu WL
    Int J Tuberc Lung Dis; 2013 Oct; 17(10):1346-53. PubMed ID: 24025389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of serum levels of angiopoietin-2 and survivin biomarkers in non-small cell lung cancer.
    Fawzy A; Gaafar R; Kasem F; Ali SS; Elshafei M; Eldeib M
    J Egypt Natl Canc Inst; 2012 Mar; 24(1):41-5. PubMed ID: 23587231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum receptor-binding cancer antigen expressed on SiSo cells (RCAS1) as a diagnostic and prognostic marker for non-small cell lung cancer.
    Xu C; Yu LK; Zhang X
    Tumori; 2014; 100(4):107e-11e. PubMed ID: 25296600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum lactate dehydrogenase levels at presentation in stage IV non-small cell lung cancer: predictive value of metastases and relation to survival outcomes.
    Lee DS; Park KR; Kim SJ; Chung MJ; Lee YH; Chang JH; Kang JH; Hong SH; Kim MS; Kim YS
    Tumour Biol; 2016 Jan; 37(1):619-25. PubMed ID: 26240025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma.
    Ardizzoni A; Cafferata MA; Paganuzzi M; Filiberti R; Marroni P; Neri M; Fontana V; Nicoló G; Perdelli L; Stampino CG; Rosso R; Puntoni R
    Cancer; 2001 Oct; 92(7):1896-904. PubMed ID: 11745263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers.
    Li BT; Lou E; Hsu M; Yu HA; Naidoo J; Zauderer MG; Sima C; Johnson ML; Daras M; DeAngelis LM; Fleisher M; Kris MG; Azzoli CG
    PLoS One; 2016; 11(1):e0146063. PubMed ID: 26730601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and Prognostic Value of Serum Angiopoietin-Like Protein 2 in Patients with Non-Small Cell Lung Cancer.
    Chen Y; Jiang H; Zhu L; Wang P; Liu S; Xiao X; Yu H; Dong W
    Clin Lab; 2017 Jan; 63(1):59-65. PubMed ID: 28164488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum interleukin-17 as a diagnostic and prognostic marker for non-small cell lung cancer.
    Xu C; Hao K; Yu L; Zhang X
    Biomarkers; 2014 Jun; 19(4):287-90. PubMed ID: 24731052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients.
    Köhler J; Schuler M; Gauler TC; Nöpel-Dünnebacke S; Ahrens M; Hoffmann AC; Kasper S; Nensa F; Gomez B; Hahnemann M; Breitenbuecher F; Cheufou D; Özkan F; Darwiche K; Hoiczyk M; Reis H; Welter S; Eberhardt WE; Eisenacher M; Teschler H; Stamatis G; Schmiegel W; Hahn SA; Baraniskin A
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):795-805. PubMed ID: 26687686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role of serum p53 antibodies in lung cancer.
    Mattioni M; Soddu S; Prodosmo A; Visca P; Conti S; Alessandrini G; Facciolo F; Strigari L
    BMC Cancer; 2015 Mar; 15():148. PubMed ID: 25884692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.